The above observations indicated that ubiquitination and glycosylation processes are strongly linked to PD-1/PD-L-1 expression and provide an important target for new therapeutic approach for improving the effectiveness of cancer immunotherapy. The gene discussed is PDCD1; the disease is cancer.